UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049669
Receipt number R000056470
Scientific Title Follow-up study in patients with re-implanted devices after transvenous lead extraction
Date of disclosure of the study information 2022/12/02
Last modified on 2022/12/02 11:24:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Follow-up study in patients with re-implanted devices after transvenous lead extraction

Acronym

Follow-up study in patients with re-implanted devices after transvenous lead extraction

Scientific Title

Follow-up study in patients with re-implanted devices after transvenous lead extraction

Scientific Title:Acronym

Follow-up study in patients with re-implanted devices after transvenous lead extraction

Region

Japan


Condition

Condition

Patients undergoing transvenous lead extraction(TLE) for implantable cardiac device infection or other reasons

Classification by specialty

Cardiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will investigate the stimulation threshold, sensing wave height, lead resistance, etc. of patients who had device re-implantation after TLE from past records to clarify the transition of follow-up data. The appropriate follow-up interval for patients who have had a device removed and reimplanted will also be examined accordingly. Based on the results, we will estimate the appropriate follow-up intervals for early detection of abnormalities in lead devices, and improve the time constraints and psychological anxiety caused by excessive device checks.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Device follow-up data for patients with device reimplanted after TLE between 2016 and 2022

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. TLE and reimplantation of the device
2. at least one device follow-up after device implantation and discharge from the hospital

Key exclusion criteria

1. If the reimplanted device is an S-ICD (subcutaneous implantable cardioverter defibrillator)
2. When device follow-up has not been performed

Target sample size

162


Research contact person

Name of lead principal investigator

1st name Tsuyoshi
Middle name
Last name Isawa

Organization

Sendai Kousei Hospital

Division name

Department of cardiology

Zip code

980-0873

Address

4-5 Hirose-machi, Aobaku, Sendai, Miyagi, Japan.

TEL

022-222-6181

Email

isa_tsuyo@yahoo.co.jp


Public contact

Name of contact person

1st name Tsuyoshi
Middle name
Last name Isawa

Organization

Sendai Kousei Hospital

Division name

Department of cardiology

Zip code

980-0873

Address

4-5 Hirose-machi, Aobaku, Sendai, Miyagi, Japan.

TEL

022-222-6181

Homepage URL


Email

isa_tsuyo@yahoo.co.jp


Sponsor or person

Institute

Sendai Kousei Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board on Sendai Kousei Hospital

Address

4-5, Hirose-machi, Aobaku, Sendai, Miyagi, Japan

Tel

022-222-6181

Email

s.takahashi@sendai-kousei-hospital.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

162

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 11 Month 28 Day

Date of IRB

2022 Year 11 Month 28 Day

Anticipated trial start date

2022 Year 11 Month 28 Day

Last follow-up date

2023 Year 02 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cardiac implantable device follow-up data from January 2017 to July 2022 were used .


Management information

Registered date

2022 Year 12 Month 02 Day

Last modified on

2022 Year 12 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056470


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name